Abstract
BackgroundTargeting interleukin-6 receptor signal transduction by tocilizumab (TCZ) has been shown to be an effective treatment for patients with rheumatoid arthritis (RA).ObjectivesThis study aimed to describe safety and efficacy of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
